Sunday, September 30, 2018

Mankind Pharma eyes $1 billion topline by FY21

Mankind Pharma eyes $1 billion topline by FY21 The company is also looking at increasing its exports substantially to $100-150 million in the next three years from the present $10 million.

from Moneycontrol Business News https://ift.tt/2Qla994

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...